Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 9, 1996, Pages 761-763

  Soriano, F ^a   Coronel, P ^b   Gimeno, M ^b   Jimenez M ^a   Garcia Corbeira P ^a   Fernandez Roblas R ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Tedec Meiji Farma SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFDITOREN; CEFOTAXIME; CEFTRIAXONE; MEROPENEM; PENICILLIN G; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029805945     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691969     Document Type: Article

References (11)

1. Tamura A, Okamoto R, Yoshida T, Yamamoto H, Kondo S, Inoue M, Mitsuhashi S: In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1988, 32: 1421-1426.
2. Miyazaki S, Miyazaki Y, Tsuji A, Nishida M, Goto S: In vitro antibacterial activity of ME1207, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1991, 35: 1691-1694.
3. Fernández-Roblas R, López JC, Ramos JM, Gimeno M, Coronel P, Soriano F: In vitro activity of cefditoren and six other antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. Journal of Antimicrobial Chemotherapy 1996, 37: 1037-1039.
4. Cherubin CE, Corrado ML, Nair SR, Gombert ME, Landesman S, Humbert G: Treatment of gram negative bacillary meningitis: role of the new cephalosporin antibiotics. Reviews of Infectious Diseases 1982, 4, Supplement: 453-454.
5. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993.
6. Tuomanen E, Durack DT, Tomasz A: Antibiotic tolerance among clinical isolates of bacteria. Antimicrobial Agents and Chemotherapy 1986, 30: 521-527.
7. Chapman S, Steigbigel RT: Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation. Journal of Infectious Diseases 1983, 147: 1078-1089.
8. Feldman WE: Concentration of bacteria in CSF of patients with bacterial meningitis. Journal of Pediatrics 1979, 88: 549-552.
9. Soriano F, Santamaria M, Ponte C, Castilla C, Fernández-Roblas R: In vivo significance of the inoculum effect of antibiotics on Escherichia coli. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 410-412.
10. Soriano F: Optimal dosage of β-lactam antibiotics: time above the MIC and inoculum effect. Journal of Antimicrobial Chemotherapy 1992, 30: 566-569.
11. Goldstein EJC, Citron DM, Cherubin CE: Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrobial Agents and Chemotherapy 1991, 35: 560-566.